2770.1000 -43.90 (-1.56%)
NSE Sep 08, 2026 15:31 PM
Volume: 127.7K
 

2770.10
-1.56%
ICICI Direct
Caplin Steriles caters mainly to the US and other regulated markets. So far, it has developed and filed 65 ANDAs in the US on its own and with partners, with 59 approvals as on date. The Company is also working on a portfolio of 55+ simple and complex Injectable and Ophthalmic products,...
Caplin Point Labs has gained 29.54% in the last 1 Year
More from Caplin Point Laboratories Ltd.
Recommended